Press Release Archives - Page 3 of 5

SparingVision Conference Participation in H1 2023 Paris, January 31, 2023 – SparingVision (“the Company”), a…

SparingVision s lead asset SPVN06 clears IND application in the US for the treatment of…

SparingVision to Participate in Upcoming Scientific and Medical Conferences Paris, October 25, 2022 – SparingVision…

SparingVision Presents Validating Data of its Lead Gene Therapy Programs, SPVN06 and SPVN20, at ESGCT 2022…

SparingVision to Highlight Progress of its lead Gene Independent Gene Therapy Programs SPVN06 and SPVN20…

SparingVision to Participate in Upcoming Investor and Industry Conferences Paris, September 22, 2022 – SparingVision…

SparingVision raises €75 Million Series B to Continue Building World-Leading Portfolio of Genomic Medicines for…

Cookie	Duration	Description
__cf_bm	1 hour	This cookie, set by Cloudflare, is used to support Cloudflare Bot Management. Further information: https://developers.cloudflare.com/fundamentals/reference/policies-compliances/cloudflare-cookies/#__cf_bm-cookie-for-cloudflare-bot-products
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie records the user consent for the cookies in the "Analytics" category.
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie records the user consent for the cookies in the "Necessary" category.
CookieLawInfoConsent	6 months	CookieYes sets this cookie to record the default button state of the corresponding category and the status of CCPA. It works only in coordination with the primary cookie.
viewed_cookie_policy	1 year	The GDPR Cookie Consent plugin sets the cookie to store whether or not the user has consented to use cookies. It does not store any personal data.